Reporting Manager
ADAR1 Capital Management, LLC
Symbol
QNRX
Shares outstanding
843,913 shares
Disclosed Ownership
58,230 shares
Ownership
6.9%
Form type
SCHEDULE 13G
Filing time
17 Feb 2026, 20:14:32 UTC
Date of event
31 Dec 2025

Sponsored

Quoteable Key Fact

"ADAR1 Capital Management, LLC disclosed 6.9% ownership in Quoin Pharmaceuticals, Ltd. American Depositary Shares, each representing thirty-five (35) Ordinary Shares, no par value per share (QNRX) on 31 Dec 2025."

Quick Takeaways

  • ADAR1 Capital Management, LLC filed SCHEDULE 13G for Quoin Pharmaceuticals, Ltd. American Depositary Shares, each representing thirty-five (35) Ordinary Shares, no par value per share (QNRX).
  • Disclosed ownership: 6.9%.
  • Date of event: 31 Dec 2025.

What Changed

  • No earlier schedule filing is available for direct comparison.
  • Current filing was accepted on 17 Feb 2026, 20:14.

Why This Matters

  • This page explains what this Schedule 13D/13G filing tells you before manager-level rows.
  • You can verify ownership claims directly against the original SEC filing.

Official SEC Source

Backed by Schedule 13D/13G

Beneficial ownership values are sourced from the original SEC Schedule 13D/13G filing.

See Original Filing

Reporting Managers (3)

Name Ownership Shares Owned sole voting power shared voting power Signature Title CIK
ADAR1 Capital Management, LLC 6.9% 58,230 0 58,230 /s/ Daniel Schneeberger Daniel Schneeberger, Manager
ADAR1 Capital Management GP, LLC 6% 50,226 0 50,226 /s/ Daniel Schneeberger Daniel Schneeberger, Manager
Daniel Schneeberger 6.9% 58,230 0 58,230 /s/ Daniel Schneeberger Daniel Schneeberger, in his individual capacity